DK1107767T3 - Sammensætning indeholdende selen til behandling af systemisk inflammatorisk responssyndrom (SIRS) - Google Patents

Sammensætning indeholdende selen til behandling af systemisk inflammatorisk responssyndrom (SIRS)

Info

Publication number
DK1107767T3
DK1107767T3 DK99940254T DK99940254T DK1107767T3 DK 1107767 T3 DK1107767 T3 DK 1107767T3 DK 99940254 T DK99940254 T DK 99940254T DK 99940254 T DK99940254 T DK 99940254T DK 1107767 T3 DK1107767 T3 DK 1107767T3
Authority
DK
Denmark
Prior art keywords
selenium
response syndrome
inflammatory response
systemic inflammatory
vitamin
Prior art date
Application number
DK99940254T
Other languages
Danish (da)
English (en)
Inventor
Xavier Forceville
Dominique Vitoux
Original Assignee
Xavier Forceville
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xavier Forceville filed Critical Xavier Forceville
Application granted granted Critical
Publication of DK1107767T3 publication Critical patent/DK1107767T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/06—Chelate

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99940254T 1998-08-31 1999-08-30 Sammensætning indeholdende selen til behandling af systemisk inflammatorisk responssyndrom (SIRS) DK1107767T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9810889A FR2782642B1 (fr) 1998-08-31 1998-08-31 Utilisation du selenium pour le traitement de patients atteints d'un syndrome de reponse inflammatoire systemique (sirs), et composition pour la mise en oeuvre du traitement

Publications (1)

Publication Number Publication Date
DK1107767T3 true DK1107767T3 (da) 2006-04-03

Family

ID=9530002

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99940254T DK1107767T3 (da) 1998-08-31 1999-08-30 Sammensætning indeholdende selen til behandling af systemisk inflammatorisk responssyndrom (SIRS)

Country Status (12)

Country Link
US (2) US6844012B1 (de)
EP (1) EP1107767B1 (de)
JP (1) JP4955147B2 (de)
AT (1) ATE309806T1 (de)
AU (1) AU760534B2 (de)
BR (1) BR9913339A (de)
CA (1) CA2341601C (de)
DE (1) DE69928410T2 (de)
DK (1) DK1107767T3 (de)
ES (1) ES2252963T3 (de)
FR (1) FR2782642B1 (de)
WO (1) WO2000012101A2 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60118759T2 (de) * 2000-05-25 2006-09-14 Boehringer Ingelheim International Gmbh Zusammensetzung zum verbesserten zellenschutz welche ein lipophiles antioxidans sowie ein hydrophilen antioxidans enthält
EP1205471A1 (de) * 2000-10-02 2002-05-15 PharmaSe, Incorporated Verfahren zur Anwendung von synthetischem L-Se-Methylselenocystein als Nahrungs- und Heilmittel und Verfahren zu seiner Herstellung
BR0209681A (pt) * 2001-05-16 2004-09-14 Xavier Forceville Método e kit para o diagnóstico in vivo ou para o monitoramento de uma doença que envolve uma reação inflamatória dentro de um paciente
US6849613B2 (en) 2001-08-29 2005-02-01 Kedar N. Prasad Multiple antioxidant micronutrients
US7449451B2 (en) * 2001-08-29 2008-11-11 Premier Micronutrient Corporation Use of multiple antioxidant micronutrients as systemic biological radioprotective agents against potential ionizing radiation risks
US20040110691A1 (en) * 2001-11-13 2004-06-10 Stamler Jonathan S. Thiol reactive agents as a therapeutic modality
AT412703B (de) * 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
EP1374892A1 (de) * 2002-06-28 2004-01-02 Braun, Jan Matthias, Dr. Arzneimittel zur Behandlung von infektiösen Krankheiten infolge Neisseria Meningitidis
DE10321029A1 (de) * 2003-05-10 2004-12-02 Sigrid Heide Arzneimittel mit Selenit
DE10349115A1 (de) * 2003-10-22 2005-06-16 Biosyn Arzneimittel Gmbh Kombinationspräparat zur Behandlung der Sepsis
FR2873376B1 (fr) * 2004-07-23 2006-11-24 Tetrahedron Sas Nouveaux seleno-hydroxyacides et leurs derives, applications en nutrition, cosmetique et pharmacie
FR2883884B1 (fr) * 2005-03-30 2012-11-09 Lallemand Sas Preparation de levures a proprietes anti-oxydantes ameliorees et leurs applications
US7901710B2 (en) * 2005-08-04 2011-03-08 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8202546B2 (en) * 2005-08-04 2012-06-19 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US7998500B2 (en) * 2005-08-04 2011-08-16 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US8263137B2 (en) * 2005-08-04 2012-09-11 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US20070082064A1 (en) * 2005-10-12 2007-04-12 Krawitz Paul L Nutritional or dietary supplement for the treatment of macular degeneration
US7897800B2 (en) * 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7687650B2 (en) * 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
KR101324578B1 (ko) 2006-02-03 2013-11-01 제이알 켐, 엘엘씨 구리 및 아연 조성물을 사용하는 노화 방지 치료법
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
WO2008082972A2 (en) * 2006-12-28 2008-07-10 Nutrition 21, Inc. A method of treating and preventing viral infections
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
US20090208543A1 (en) * 2008-01-22 2009-08-20 Oral Health Clinical Services Method and apparatus for applying a protective oral care composition
EP2297183A4 (de) * 2008-05-09 2012-07-04 Univ Duke Auf der entdeckung, dass thioredoxin die stickoxidfreisetzung in zellen vermittelt, beruhende behandlung von krankheiten
CA2750636C (en) 2009-01-23 2017-07-25 Jr Chem, Llc Rosacea treatments and kits for performing them
US20110008271A1 (en) * 2009-07-13 2011-01-13 Jr Chem, Llc Rosacea treatments using polymetal complexes
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
AT511159A1 (de) 2011-02-16 2012-09-15 Selo Medical Gmbh Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen
US10499682B2 (en) 2014-08-25 2019-12-10 New Age Beverage Corporation Micronutrient formulation in electronic cigarettes
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
FR3037798A1 (fr) * 2015-06-25 2016-12-30 Serenite-Forceville Composition comprenant au moins un compose selenie pour le traitement du sepsis et/ou de toute hyper-inflammation generalisee (sirs) ou cellulaire dommageable
EP3675846A4 (de) * 2017-08-29 2021-05-19 National Jewish Health Verfahren und zusammensetzungen zur behandlung von infektionen und entzündungen mit selenocyanat
US20210363601A1 (en) * 2018-05-07 2021-11-25 Yale University Test to distinguish viral-only from bacterial infection or viral/bacterial coinfection using a respiratory swab
CN111568921A (zh) * 2020-04-20 2020-08-25 奥格生物技术（六安）有限公司 一种促进冠状病毒患者康复的新型硒制剂配方及其制备方法
WO2022006426A1 (en) 2020-07-02 2022-01-06 American Regent, Inc. Trace element compositions, methods of making and use
CN111748533B (zh) * 2020-07-03 2021-04-02 华中农业大学 白蚁SelT基因及其dsRNA结合金龟子绿僵菌在白蚁防治中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5929063A (en) * 1995-03-24 1999-07-27 Children's Hospital Medical Center Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
IT1290907B1 (it) * 1997-01-31 1998-12-14 Idi Farmaceutici Spa Composizione per prodotto dietetico efficace nel combattere lo stress ossidativo e il decadimento cellulare.
GB9722361D0 (en) * 1997-10-24 1997-12-17 Pharma Nord Uk Ltd Pharmaceutical formulation for treating liver disorders

Also Published As

Publication number Publication date
US20050163862A1 (en) 2005-07-28
DE69928410D1 (de) 2005-12-22
JP2002523463A (ja) 2002-07-30
AU760534B2 (en) 2003-05-15
CA2341601C (fr) 2011-10-25
JP4955147B2 (ja) 2012-06-20
CA2341601A1 (fr) 2000-03-09
DE69928410T2 (de) 2006-08-03
BR9913339A (pt) 2001-05-15
WO2000012101A3 (fr) 2000-06-15
FR2782642A1 (fr) 2000-03-03
EP1107767B1 (de) 2005-11-16
EP1107767A2 (de) 2001-06-20
US7635491B2 (en) 2009-12-22
WO2000012101A2 (fr) 2000-03-09
ATE309806T1 (de) 2005-12-15
US6844012B1 (en) 2005-01-18
FR2782642B1 (fr) 2001-12-07
AU5427099A (en) 2000-03-21
ES2252963T3 (es) 2006-05-16

Similar Documents

Publication Publication Date Title
DK1107767T3 (da) Sammensætning indeholdende selen til behandling af systemisk inflammatorisk responssyndrom (SIRS)
DE69905368D1 (en) Oxydiertes thymosin beta 4
ATE233735T1 (de) Neue phenanthridine
TR200002218T2 (tr) 2-(Pürin-9-il)-Tetrahidrofüran -3,4-Diol türevleri
EP2266607A3 (de) Immunokonjugate für Krebsbehandlung
AU7371600A (en) Use of alpha-linolenic acid metabolites for treatment or prevention of cancer
SE9803986D0 (sv) New compositions
BG105783A (en) Triazole compounds with dopamine-d3-receptor affinity
TR200000928T2 (tr) Yeni kombinasyon.
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
BRPI0411319A (pt) compostos terapeuticamente ativos e sua utilização
AU6200599A (en) Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of acomposition for the treatment of ischemic stroke
MY101520A (en) Indoline and 2-indolinone derivatives.
DE69718469D1 (de) Verbindungen mit wachtumshormon freisetzenden eigenschaften
AU1556800A (en) Hyperforin as cytostatic agent and hyperforin ointment or cream as application form
BR9910622A (pt) Novas composições
ATE500269T1 (de) Verbindungen mit wachstumshormon-freisetzenden eigenschaften
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
ATE286739T1 (de) Verwendung einer pollenextrakt-haltigen verbindung zur behandlung erkrankungsbedingter gewichtszunahme
TR200200987T2 (tr) Kanser tedavisine yönelik,ornatılmış pirroller
DK227090D0 (da) Organisk guldkompleks til topisk anvendelse
TR200003521T2 (tr) Yeniden-kombine-edilen insan interferonu beta-1a (IFN-beta-1a) formülasyonu.
MD980129A (en) Antiherpetic remedy
NO20012169D0 (no) Forbindelser med veksthormonfrigjörende egenskaper
Han Changes in the Nursing Related Regulations-in Medical Law